Exact Mass: 460.04534780000006

Exact Mass Matches: 460.04534780000006

Found 64 metabolites which its exact mass value is equals to given mass value 460.04534780000006, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   
   

Flupoxam

1-[4-chloro-3-[(2,2,3,3,3-Pentafluoropropoxy)methyl]phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide, 9ci

C19H14ClF5N4O2 (460.0725394)


Pre- and post emergence herbicide for broad-leaved weed control in winter cereals. Pre- and post emergence herbicide for broad-leaved weed control in winter cereals

   

N-Desmethyl vandetanib

N-(4-bromo-2-fluorophenyl)-6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-amine

C21H22BrFN4O2 (460.09100639999997)


N-Desmethyl vandetanib is a metabolite of vandetanib. Vandetanib (rINN, trade name Caprelsa), also known as ZD6474, is an antagonist of the vascular endothelial growth factor receptor (VEGFR) and the epidermal growth factor receptor (EGFR). It is a tyrosine kinase inhibitor, being developed by AstraZeneca. It has a third target: inhibiting RET-tyrosine kinase activity, an important growth driver in certain types of thyroid cancer (Wikipedia)

   

5-Carboxyfluorescein diacetate

3,6-bis(acetyloxy)-3-oxo-3H-spiro[2-benzofuran-1,9-xanthene]-5-carboxylic acid

C25H16O9 (460.0794286)


D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

   

6-Carboxyfluorescein diacetate

3,6-bis(acetyloxy)-3-oxo-3H-spiro[2-benzofuran-1,9-xanthene]-6-carboxylic acid

C25H16O9 (460.0794286)


D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

   

3',6'-Diacetyloxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-4-carboxylic acid

3,6-bis(acetyloxy)-3-oxo-3H-spiro[2-benzofuran-1,9-xanthene]-4-carboxylic acid

C25H16O9 (460.0794286)


   

Tecarfarin

1,1,1,3,3,3-Hexafluoro-2-methylpropan-2-yl 4-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]benzoic acid

C21H14F6O5 (460.07453860000004)


C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

   

(+)-5-Bromoochrephilone

(+)-5-Bromoochrephilone

C23H25BrO5 (460.088526)


   

Spriropreussione B

Spriropreussione B

C29H16O6 (460.0946836)


   
   
   
   
   

Malonprotocetraric acid

Malonprotocetraric acid

C21H16O12 (460.0641736)


   
   
   
   

Schimperiquinone B

Schimperiquinone B

C29H16O6 (460.0946836)


   
   
   

Rhein glucuronide 2

Rhein glucuronide 2

C21H16O12 (460.0641736)


   
   
   
   

Triphenylphenacylphosphonium bromide

Triphenylphenacylphosphonium bromide

C26H22BrOP (460.0591552)


   

1,3-diethyl-4,2-quinolylthiacyanineiodide

1,3-diethyl-4,2-quinolylthiacyanineiodide

C21H21IN2S (460.0470136)


   

4-METHOXYPHENOXYACETICACID

4-METHOXYPHENOXYACETICACID

C22H25BrN2O2S (460.082001)


   

(3-(DIBROMOMETHYLENE)-5-(TRIISOPROPYLSILYL)PENTA-1,4-DIYN-1-YL)TRIMETHYLSILANE

(3-(DIBROMOMETHYLENE)-5-(TRIISOPROPYLSILYL)PENTA-1,4-DIYN-1-YL)TRIMETHYLSILANE

C18H30Br2Si2 (460.025266)


   

5(6)-Carboxyfluorescein Diacetate

5(6)-Carboxyfluorescein Diacetate

C25H16O9 (460.0794286)


   

C3-oxacyanine

3,3-Diethyloxacarbocyanine iodide

C21H21IN2O2 (460.0647716)


D004396 - Coloring Agents > D002232 - Carbocyanines

   
   
   

Cocarboxylase

Thiamine pyrophosphate

C12H19ClN4O7P2S (460.0138194)


D018977 - Micronutrients > D014815 - Vitamins Thiamine pyrophosphate is the active form of thiamine, and it serves as a cofactor for several enzymes involved primarily in carbohydrate catabolism. The enzymes are important in the biosynthesis of a number of cell constituents, including neurotransmitters, and for the production of reducing equivalents used in oxidant stress defenses and in biosyntheses and for synthesis of pentoses used as nucleic acid precursors. The chemical structure of TPP is that of an aromatic methylaminopyrimidine ring, linked via a methylene bridge to a methylthiazolium ring with a pyrophosphate group attached to a hydroxyethyl side chain. In non-enzymatic model studies it has been demonstrated that the thiazolium ring can catalyse reactions which are similar to those of TPP-dependent enzymes but several orders of magnitude slower. Using infrared and NMR spectrophotometry it has been shown that the dissociation of the proton from C2 of the thiazolium ring is necessary for catalysis; the abstraction of the proton leads to the formation of a carbanion (ylid) with the potential for a nucleophilic attack on the carbonyl group of the substrate. In all TPP-dependent enzymes the abstraction of the proton from the C2 atom is the first step in catalysis, which is followed by a nucleophilic attack of this carbanion on the substrate. Subsequent cleavage of a C-C bond releases the first product with formation of a second carbanion (2-greek small letter alpha-carbanion or enamine). The formation of this 2-greek small letter alpha-carbanion is the second feature of TPP catalysis common to all TPP-dependent enzymes. Depending on the enzyme and the substrate(s), the reaction intermediates and products differ. Methyl-branched fatty acids, as phytanic acid, undergo peroxisomal beta-oxidation in which they are shortened by 1 carbon atom. This process includes four steps: activation, 2-hydroxylation, thiamine pyrophosphate dependent cleavage and aldehyde dehydrogenation. In the third step, 2-hydroxy-3-methylacyl-CoA is cleaved in the peroxisomal matrix by 2-hydroxyphytanoyl-CoA lyase (2-HPCL), which uses thiamine pyrophosphate (TPP) as cofactor. The thiamine pyrophosphate dependence of the third step is unique in peroxisomal mammalian enzymology. Human pathology due to a deficient alpha-oxidation is mostly linked to mutations in the gene coding for the second enzyme of the sequence, phytanoyl-CoA hydroxylase (EC 1.14.11.18). (PMID: 12694175, 11899071, 9924800) [HMDB] Thiamine pyrophosphate is the coenzyme form of Vitamin B1 and is a required intermediate in the pyruvate dehydrogenase complex and the ketoglutarate dehydrogenase complex.

   

4-[(4-chloro-2-nitrophenyl)azo]-3-hydroxy-N-(2-methylphenyl)naphthalene-2-carboxamide

4-[(4-chloro-2-nitrophenyl)azo]-3-hydroxy-N-(2-methylphenyl)naphthalene-2-carboxamide

C24H17ClN4O4 (460.0938272)


   
   

Flupoxam

1-[4-chloro-3-(2,2,3,3,3-pentafluoropropoxymethyl)phenyl]-5-phenyl-1,2 ,4-triazole-3-carboxamide

C19H14ClF5N4O2 (460.0725394)


   

3(or 6)-Carboxy-9,10-dihydro-9,10-dioxo-1-anthracenyl beta-D-glucopyranosiduronic acid

3(or 6)-Carboxy-9,10-dihydro-9,10-dioxo-1-anthracenyl beta-D-glucopyranosiduronic acid

C21H16O12 (460.0641736)


   
   

1-[(2,6-Difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine

1-[(2,6-Difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine

C18H18F2N2O6S2 (460.0574312)


   

2-((4aR,5R,5aR,8aR,9S)-10-(4-fluorophenyl)-2,6,8-trioxo-2,3,4a,5,5a,6,8a,9,9a,10-decahydro-5,9-methanothiazolo[5,4:5,6]thiopyrano[2,3-f]isoindol-7(8H)-yl)acetic acid

2-((4aR,5R,5aR,8aR,9S)-10-(4-fluorophenyl)-2,6,8-trioxo-2,3,4a,5,5a,6,8a,9,9a,10-decahydro-5,9-methanothiazolo[5,4:5,6]thiopyrano[2,3-f]isoindol-7(8H)-yl)acetic acid

C21H17FN2O5S2 (460.05628839999997)


   
   

Tecarfarin

Tecarfarin

C21H14F6O5 (460.07453860000004)


C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

   

[[5-(4-Amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-(methylamino)ethyl hydrogen phosphate

[[5-(4-Amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-(methylamino)ethyl hydrogen phosphate

C12H22N4O11P2 (460.07602819999994)


   

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-[3-(hydroxyamino)propyl]phosphinic acid

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-[3-(hydroxyamino)propyl]phosphinic acid

C12H22N4O11P2 (460.07602819999994)


   

N-[1-(2,6-difluorophenyl)sulfonyl-3-pyrrolidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

N-[1-(2,6-difluorophenyl)sulfonyl-3-pyrrolidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

C18H18F2N2O6S2 (460.0574312)


   

N-[[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-azetidinyl]methyl]-2,6-difluorobenzenesulfonamide

N-[[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-azetidinyl]methyl]-2,6-difluorobenzenesulfonamide

C18H18F2N2O6S2 (460.0574312)


   

N-[[1-(2,6-difluorophenyl)sulfonyl-3-azetidinyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

N-[[1-(2,6-difluorophenyl)sulfonyl-3-azetidinyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

C18H18F2N2O6S2 (460.0574312)


   

N-[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-pyrrolidinyl]-2,6-difluorobenzenesulfonamide

N-[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-pyrrolidinyl]-2,6-difluorobenzenesulfonamide

C18H18F2N2O6S2 (460.0574312)


   

4-chloro-N-[3-[(3,5-dimethyl-4-isoxazolyl)methylthio]-2-quinoxalinyl]benzenesulfonamide

4-chloro-N-[3-[(3,5-dimethyl-4-isoxazolyl)methylthio]-2-quinoxalinyl]benzenesulfonamide

C20H17ClN4O3S2 (460.04305619999997)


   

2-(1-Naphthalenyl)acetic acid [2-[4-chloro-3-(dimethylsulfamoyl)anilino]-2-oxoethyl] ester

2-(1-Naphthalenyl)acetic acid [2-[4-chloro-3-(dimethylsulfamoyl)anilino]-2-oxoethyl] ester

C22H21ClN2O5S (460.08596460000007)


   

2-[[2-[[4-hydroxy-6-oxo-5-(phenylmethyl)-1H-pyrimidin-2-yl]thio]-1-oxoethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester

2-[[2-[[4-hydroxy-6-oxo-5-(phenylmethyl)-1H-pyrimidin-2-yl]thio]-1-oxoethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester

C20H20N4O5S2 (460.087507)


   

2-(3,4-dihydroxyphenyl)-7-(beta-D-glucopyranuronosyloxy)-4-oxo-4H-chromen-5-olate

2-(3,4-dihydroxyphenyl)-7-(beta-D-glucopyranuronosyloxy)-4-oxo-4H-chromen-5-olate

C21H16O12-2 (460.0641736)


   

N-(4-chlorophenyl)-2-[[4-methyl-5-[4-methyl-2-(5-methyl-3-isoxazolyl)-5-thiazolyl]-1,2,4-triazol-3-yl]thio]acetamide

N-(4-chlorophenyl)-2-[[4-methyl-5-[4-methyl-2-(5-methyl-3-isoxazolyl)-5-thiazolyl]-1,2,4-triazol-3-yl]thio]acetamide

C19H17ClN6O2S2 (460.05428919999997)


   

2-[4-Hydroxy-6-(toluene-4-sulfonylamino)-pyrimidin-2-ylsulfanyl]-N-(4-methoxy-phenyl)-acetamide

2-[4-Hydroxy-6-(toluene-4-sulfonylamino)-pyrimidin-2-ylsulfanyl]-N-(4-methoxy-phenyl)-acetamide

C20H20N4O5S2 (460.087507)


   

2-Piperidin-1-yl-1-(3,9,11-trichloro-5,6-dihydrobenzo[c]acridin-7-yl)ethanol

2-Piperidin-1-yl-1-(3,9,11-trichloro-5,6-dihydrobenzo[c]acridin-7-yl)ethanol

C24H23Cl3N2O (460.0875878)


   

(E)-6,6,6-trichloro-3-methoxy-N,5-dimethyl-N-[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide

(E)-6,6,6-trichloro-3-methoxy-N,5-dimethyl-N-[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide

C20H23Cl3N2O2S (460.0545748)


   

3,8,18,23-Tetrahydroxy-10,16-dimethyl-5,21-dioxaheptacyclo[11.9.1.11,15.14,7.02,12.011,25.019,24]pentacosa-2(12),3,7,9,11(25),15(24),16,18-octaene-6,14,20-trione

3,8,18,23-Tetrahydroxy-10,16-dimethyl-5,21-dioxaheptacyclo[11.9.1.11,15.14,7.02,12.011,25.019,24]pentacosa-2(12),3,7,9,11(25),15(24),16,18-octaene-6,14,20-trione

C25H16O9 (460.0794286)


   

luteolin 7-O-beta-D-glucosiduronate(2-)

luteolin 7-O-beta-D-glucosiduronate(2-)

C21H16O12 (460.0641736)


A carbohydrate acid derivative anion arising from deprotonation of the carboxy and 5-hydroxy groups of luteolin 7-O-beta-D-glucosiduronic acid; major species at pH 7.3 (according to Marvin v 6.2.0.).